Tuesday 13 October 2026 Export ASMB’s income statement to Excel — free account

Assembly Biosciences, Inc.

Assembly Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $72.3 million, up 153.5% from fiscal 2024. In the quarter to June 2026, revenue grew 38.9%, EPS grew 85.0% and free cash flow grew 7.58%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

20.65 2.12 −9.31%

Follow ASMB

Alert me

Market cap: $463.6M
P/E: 22.3×
Fwd P/E: −21.1×
Dividend yield: —
F-score: 4/9
Altman Z: 1.06
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	26.94
P/S ratio Full definition →		8.73	5.27	6.60	6.92
P/FCF ratio Full definition →		0.00	0.00	0.00	0.00
P/Operating CF Full definition →		(21.46)	26.78	(21.22)	(33.45)
P/B ratio Full definition →		1.78	1.84	2.36	1.70
Price to Tangible BV Full definition →		2.30	2.31	2.99	1.96
EV/Sales Full definition →		2.48	1.84	3.41	2.64
EV/EBITDA Full definition →		0.00	0.00	0.00	0.00
EV/Operating CF Full definition →		(1.65)	(3.24)	(6.10)	(5.14)
EV/FCF Full definition →		(1.65)	(3.24)	(6.08)	(5.13)
Quick Ratio Full definition →		4.37	5.11	6.49	13.70
Current Ratio Full definition →		4.44	5.22	6.65	13.99
Net Debt/EBITDA Full definition →		20.25	(13.06)	18.68	45.17
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		0.22	0.38	0.43	0.36
Operating CF/Net income Full definition →		1.65	0.64	2.43	4.02
Capex/Depreciation Full definition →		0.07	0.03	0.02	0.00
Interest Coverage Full definition →		—	—	—	2.55
Research and Development Expense of Revenue Full definition →		153.74%	40.62%	181.42%	111.54%
Selling, General and Administrative Expense of Revenue Full definition →		47.13%	12.76%	57.02%	35.90%
Intangible Assets out of Total Assets Full definition →		0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →		15.48%	3.44%	13.59%	18.06%
Graham Net Nets Full definition →		0.55	0.53	0.42	0.58
Graham Number Full definition →		0.00	0.00	0.00	19.29
Earnings Yield Full definition →		(18.71%)	(2.18%)	(0.40%)	3.71%
Free Cash Flow Yield Full definition →		(17.18%)	(10.79%)	(8.49%)	(7.44%)
Revenue per Share Full definition →		0.85	3.79	0.49	0.71
Operating CF per Share Full definition →		(1.19)	1.27	(1.31)	(0.82)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		(1.20)	1.27	(1.31)	(0.82)
Cash per Share Full definition →		18.33	22.13	13.41	16.99
Shareholders Equity per Share Full definition →		14.40	18.44	11.75	16.21
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		14.40	18.44	11.75	16.21
Free Cash Flow Full definition →		(15.17)	14.21	(22.12)	(15.49)
Working Capital Full definition →		183.43	205.77	197.62	304.53
Capital Expenditures Full definition →		(0.04)	(0.02)	(0.02)	0.00
Net Current Asset Value Full definition →		179.51	203.71	195.72	302.80
EV/EBIT Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	0.00	0.00
Price to Operating Income Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →		0.63	0.54	0.25	0.43
Average Payables Full definition →		1.51	0.88	1.00	0.96
Average Assets Full definition →		170.13	188.38	167.26	205.81
Average Common Equity Full definition →		104.35	120.06	112.87	161.87

Show all line items

Columns are period end dates

Stockrow Weekly